Medical Condition News

RSS

Study points to a new, effective treatment option for patients with mesothelioma

Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for patients who have inoperable pleural mesothelioma, a cancer of the tissues lining the lungs, according to a phase II clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

8 Nov 2021

COVID-19 lockdowns and young people's mental health

In the current study, the researchers looked at earlier papers for evidence of the impact of lockdowns on the mental health of the population.

8 Nov 2021

More inflammation found in Black patients with prurigo nodularis

Prurigo nodularis (PN) is a chronic skin disease that affects an estimated 72 out of 100,000 people in the U.S. The disease disproportionately affects Black patients and other minority groups.

8 Nov 2021

Study reveals the role of SPOP protein in an inherited form of ALS

The damaging effects of toxic proteins created in one inherited form of amyotrophic lateral sclerosis (ALS) are mediated by a protein called SPOP, according to a study published in the Proceedings of the National Academy of the Sciences.

8 Nov 2021

Alzheimer’s Disease – A Global Response to a Global Challenge

Alzheimer’s Disease remains both a current issue and a future challenge. Levels of the disease in the European Union have been predicted to double from the current estimate of 7,853,705 to 14,298,671 by 2050

From Biophys Ltd. 8 Nov 2021

Study highlights the importance of reducing air pollution to prevent heart attacks

Reduced air pollution in the U.S. during the COVID-19 shutdown initiated in March 2020 was linked to fewer severe heart attacks, according to preliminary research to be presented at the American Heart Association's Scientific Sessions 2021.

8 Nov 2021

Researchers identify new symptoms associated with pancreatic cancer

Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognized symptoms – feeling thirsty and having dark urine – in a study presented today (Monday) at the NCRI Festival.

8 Nov 2021

Childhood kidney cancers continue to be diagnosed at later stages in the UK and Ireland

Children with kidney cancers continue to be diagnosed with larger and more advanced tumours in the UK and Ireland than in other Western European countries, according to research presented at the NCRI Festival.

8 Nov 2021

Study looks at how lupus genetics intersects with COVID-19

The study “Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19” was recently published on the preprint medRxiv* server.

8 Nov 2021

The importance of exercise for those with diabetes in the COVID era

A review aims to evaluate the effectiveness of physical activity in people with type 2 diabetes and COVID-19.

7 Nov 2021

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

A new study proposed that the RNA structure and the genome component may serve as an important basis of different deamination spectrums in SARS-CoV-2.

7 Nov 2021

Dramatic reduction in cervical cancer in the UK following the introduction of HPV vaccination

The current study assessed the impact of HPV vaccination on the rates of cervical cancer and cervical carcinoma in situ.

7 Nov 2021

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Patients with two out of the three most common types of advanced breast cancer now have an average survival time of at least five years, according to a panel of experts at the Advanced Breast Cancer Sixth International Consensus Conference (ABC 6).

7 Nov 2021

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related benefits for people with type 2 diabetes.

7 Nov 2021

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

7 Nov 2021

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called "long-haul" COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

7 Nov 2021

Global effort focuses on developing better methods to quantify joint damage in rheumatoid arthritis patients

Crowdsourcing has become an increasingly popular way to develop machine learning algorithms to address many clinical problems in a variety of illnesses.

7 Nov 2021

Diabetes medication reduces the rate of kidney function decline in CKD patients

Clinical trial data reveal that dapagliflozin - a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes - reduces the rate of kidney function decline in patients with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2021 November 4–November 7.

7 Nov 2021

Some immune checkpoint inhibitors can cause serious arrhythmias and myocarditis

Immune checkpoint inhibitors (ICIs) have transformed cancer care by unleashing T-cells to fight tumors, but they can cause serious cardiotoxicities including myocarditis. ICI-induced myocarditis represents a new clinical syndrome because of the novelty and considerable usage of ICIs.

7 Nov 2021

Therapeutics that target ceramides may help treat cardiometabolic disease

Therapeutics that target lipids called ceramides might hold potential for treating cardiometabolic disease, argues a review article published November 5th in the journal Trends in Pharmacological Sciences.

7 Nov 2021

Medical Condition News

Study points to a new, effective treatment option for patients with mesothelioma

COVID-19 lockdowns and young people's mental health

More inflammation found in Black patients with prurigo nodularis

Study reveals the role of SPOP protein in an inherited form of ALS

Alzheimer’s Disease – A Global Response to a Global Challenge

Study highlights the importance of reducing air pollution to prevent heart attacks

Researchers identify new symptoms associated with pancreatic cancer

Childhood kidney cancers continue to be diagnosed at later stages in the UK and Ireland

Study looks at how lupus genetics intersects with COVID-19

The importance of exercise for those with diabetes in the COVID era

Fast evolution of SARS-CoV-2 driven by extensive RNA deamination by host cells

Dramatic reduction in cervical cancer in the UK following the introduction of HPV vaccination

Experts reveal improved survival for patients with two out of three types of advanced breast cancer

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

Global effort focuses on developing better methods to quantify joint damage in rheumatoid arthritis patients

Diabetes medication reduces the rate of kidney function decline in CKD patients

Some immune checkpoint inhibitors can cause serious arrhythmias and myocarditis

Therapeutics that target ceramides may help treat cardiometabolic disease

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News